152 related articles for article (PubMed ID: 23523321)
21. Adaptive radiotherapy for locally advanced non-small-cell lung cancer does not underdose the microscopic disease and has the potential to increase tumor control.
Guckenberger M; Richter A; Wilbert J; Flentje M; Partridge M
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):e275-82. PubMed ID: 21497450
[TBL] [Abstract][Full Text] [Related]
22. Technical feasibility of novel immunostimulatory low-dose radiation for polymetastatic disease with CBCT-based online adaptive and conventional approaches.
Nasser N; Perez BA; Penagaricano JA; Caudell JJ; Oliver DE; Latifi K; Moros EG; Redler G
J Appl Clin Med Phys; 2024 Jun; 25(6):e14303. PubMed ID: 38377378
[TBL] [Abstract][Full Text] [Related]
23. Accumulation of the delivered dose based on cone-beam CT and deformable image registration for non-small cell lung cancer treated with hypofractionated radiotherapy.
Wang B; Wang DQ; Lin MS; Lu SP; Zhang J; Chen L; Li QW; Cheng ZK; Liu FJ; Guo JY; Liu H; Qiu B
BMC Cancer; 2020 Nov; 20(1):1112. PubMed ID: 33198676
[TBL] [Abstract][Full Text] [Related]
24. A feasibility study of dynamic adaptive radiotherapy for nonsmall cell lung cancer.
Kim M; Phillips MH
Med Phys; 2016 May; 43(5):2153. PubMed ID: 27147327
[TBL] [Abstract][Full Text] [Related]
25. Comparison of different dose accumulation strategies to estimate organ doses after stereotactic magnetic resonance-guided adaptive radiotherapy.
Regnery S; Leiner L; Buchele C; Hoegen P; Sandrini E; Held T; Deng M; Eichkorn T; Rippke C; Renkamp CK; König L; Lang K; Adeberg S; Debus J; Klüter S; Hörner-Rieber J
Radiat Oncol; 2023 May; 18(1):92. PubMed ID: 37248504
[TBL] [Abstract][Full Text] [Related]
26. Potential for adaptive dose escalation in radiotherapy for patients with locally advanced non-small-cell lung cancer in a low mid income setting.
Agrawal S; Kumar S; Maurya AK
Br J Radiol; 2017 Feb; 90(1070):20140234. PubMed ID: 27897060
[TBL] [Abstract][Full Text] [Related]
27. Dose distribution and tumor control probability in out-of-field lymph node stations in intensity modulated radiotherapy (IMRT) vs 3D-conformal radiotherapy (3D-CRT) of non-small-cell lung cancer: an in silico analysis.
Fleckenstein J; Eschler A; Kremp K; Kremp S; Rübe C
Radiat Oncol; 2015 Aug; 10():178. PubMed ID: 26292716
[TBL] [Abstract][Full Text] [Related]
28. Evaluation of adaptive treatment planning for patients with non-small cell lung cancer.
Zhong H; Siddiqui SM; Movsas B; Chetty IJ
Phys Med Biol; 2017 Jun; 62(11):4346-4360. PubMed ID: 28072395
[TBL] [Abstract][Full Text] [Related]
29. Impact of four-dimensional computed tomography pulmonary ventilation imaging-based functional avoidance for lung cancer radiotherapy.
Yamamoto T; Kabus S; von Berg J; Lorenz C; Keall PJ
Int J Radiat Oncol Biol Phys; 2011 Jan; 79(1):279-88. PubMed ID: 20646852
[TBL] [Abstract][Full Text] [Related]
30. Functional image-guided radiotherapy planning in respiratory-gated intensity-modulated radiotherapy for lung cancer patients with chronic obstructive pulmonary disease.
Kimura T; Nishibuchi I; Murakami Y; Kenjo M; Kaneyasu Y; Nagata Y
Int J Radiat Oncol Biol Phys; 2012 Mar; 82(4):e663-70. PubMed ID: 22245191
[TBL] [Abstract][Full Text] [Related]
31. The potential for increased tumor control probability in non-small cell lung cancer with a hypofractionated integrated boost to the gross tumor volume.
Fleming C; O'Keeffe S; Dunne M; Armstrong JG; McClean B; Vintro LL
Med Dosim; 2018 Winter; 43(4):352-357. PubMed ID: 29289456
[TBL] [Abstract][Full Text] [Related]
32. Adaptive/nonadaptive proton radiation planning and outcomes in a phase II trial for locally advanced non-small cell lung cancer.
Koay EJ; Lege D; Mohan R; Komaki R; Cox JD; Chang JY
Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):1093-100. PubMed ID: 22543217
[TBL] [Abstract][Full Text] [Related]
33. Predictive treatment management: incorporating a predictive tumor response model into robust prospective treatment planning for non-small cell lung cancer.
Zhang P; Yorke E; Hu YC; Mageras G; Rimner A; Deasy JO
Int J Radiat Oncol Biol Phys; 2014 Feb; 88(2):446-52. PubMed ID: 24315562
[TBL] [Abstract][Full Text] [Related]
34. A planning study of radiotherapy dose escalation of PET-active tumour volumes in non-small cell lung cancer patients.
Møller DS; Khalil AA; Knap MM; Muren LP; Hoffmann L
Acta Oncol; 2011 Aug; 50(6):883-8. PubMed ID: 21767188
[TBL] [Abstract][Full Text] [Related]
35.
Qiu J; Lv B; Fu M; Wang X; Zheng X; Zhuo W
Head Neck; 2017 Dec; 39(12):2519-2527. PubMed ID: 28963789
[TBL] [Abstract][Full Text] [Related]
36. Interfraction displacement of primary tumor and involved lymph nodes relative to anatomic landmarks in image guided radiation therapy of locally advanced lung cancer.
Jan N; Balik S; Hugo GD; Mukhopadhyay N; Weiss E
Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):210-5. PubMed ID: 24239387
[TBL] [Abstract][Full Text] [Related]
37. Chemoradiotherapy by intensity-modulated radiation therapy with simultaneous integrated boost in locally advanced or oligometastatic non-small-cell lung cancer-a two center experience.
Mantel F; Müller E; Kleine P; Zimmermann M; Exner F; Richter A; Weick S; Ströhle S; Polat B; Höcht S; Flentje M
Strahlenther Onkol; 2021 May; 197(5):405-415. PubMed ID: 33725133
[TBL] [Abstract][Full Text] [Related]
38. Adaptive carbon ion radiotherapy for locally advanced non-small cell lung cancer: Organ-sparing potential and target coverage.
Jia S; Chen J; Ma N; Zhao J; Mao J; Jiang G; Lu J; Wu K
Med Phys; 2022 Jun; 49(6):3980-3989. PubMed ID: 35192194
[TBL] [Abstract][Full Text] [Related]
39. Stereotactic ablative radiotherapy for ultra-central lung tumors: prioritize target coverage or organs at risk?
Murrell DH; Laba JM; Erickson A; Millman B; Palma DA; Louie AV
Radiat Oncol; 2018 Apr; 13(1):57. PubMed ID: 29606150
[TBL] [Abstract][Full Text] [Related]
40. Isotoxic dose escalation in the treatment of lung cancer by means of heterogeneous dose distributions in the presence of respiratory motion.
Baker M; Nielsen M; Hansen O; Jahn JW; Korreman S; Brink C
Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):849-55. PubMed ID: 21570211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
